Position in IDXX
as of Jun 30, 2026
· filed Jul 21, 2026
Position Value
$2,616,406
-$130,674 QoQ
Shares Held
4,970
+1.7% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
#459
of 1,286 holders
Holding Since
Sep 2020
10 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in IDXX Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026J.W. COLE ADVISORS, INC. holds $8,065,103 across 7 Diagnostics & Research names. IDXX ranks #2 (32.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
5,919 | $2,967,549 | |
| 2 | IDXX |
Idexx Laboratories Inc /De
This page
|
4,970 | $2,616,406 | |
| 3 | DHR |
Danaher Corp /De/
|
5,562 | $1,059,449 | |
| 4 | LH |
Labcorp Holdings Inc.
|
1,551 | $434,280 | |
| 5 | RVTY |
Revvity, Inc.
|
2,990 | $332,667 | |
| 6 | DGX |
Quest Diagnostics Inc
|
1,550 | $328,522 | |
| 7 | A |
Agilent Technologies, Inc.
|
2,456 | $326,230 |
All Filings in IDXX
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,616,406 | 4,970 | Shares | Sole | 2026-07-21 | |
| 2026-03-31 | $2,747,080 | 4,889 | Shares | Sole | 2026-04-23 | |
| 2025-12-31 | $3,283,200 | 4,853 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $2,945,921 | 4,611 | Shares | Sole | 2025-11-05 | |
| 2025-06-30 | $2,378,131 | 4,434 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $1,677,280 | 3,994 | Shares | Sole | 2025-05-05 | |
| 2024-12-31 | $1,141,094 | 2,760 | Shares | Sole | 2025-01-31 | |
| 2024-09-30 | $1,334,791 | 2,642 | Shares | Sole | 2024-10-24 | |
| 2024-06-30 | $648,950 | 1,332 | Shares | Sole | 2024-08-08 | |
| 2020-09-30 | $978,843 | 2,490 | Shares | Sole | 2020-11-05 | |
| No filing history on record for this holder in this stock. | ||||||